Brief: Caredx Reiterates Position That It Does Not Infringe The ‘544 Patent, Injunction Motion Is Irrelevant

CareDx

29/05/2024 13:08

May 29 (Reuters) - CareDx Inc  CDNA.O :
    * CAREDX REITERATES POSITION THAT IT DOES NOT INFRINGE THE
‘544
PATENT, INJUNCTION MOTION IS IRRELEVANT
    * CAREDX INC - INJUNCTION MOTION HAS NO IMPACT ON CAREDX'S
BUSINESS OR PATIENT AND CLINICIAN ACCESS TO ALLOSURE OR ALLOMAP
    * CAREDX INC - UNDERLYING VALIDITY OF '544 PATENT ALSO
REMAINS
SUBJECT TO JUDICIAL REVIEW.

Source text for Eikon:  ID:nBw7GwTkja 
Further company coverage:  CDNA.O 

 ((Reuters.Briefs@thomsonreuters.com;))